Figure 2.
TBM induce severe lethal GVHD. Lethally irradiated B6D2F1 recipients were reconstituted with B6-derived HSCs (n = 8), HSCs plus 200 000 CD8+ TBM (n = 9), or HSCs plus 200 000 TSP (n = 14) and were assessed for survival. The inoculum containing CD8+TBM resulted in death from lethal GVHD, similar to that seen with αβTCR+ TSP used as a positive GVHD control (P = NS). Survival was markedly decreased for TBM and TSP compared with HSCs alone (P < .05 for both groups at 30 days).